Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation.

[1]  A. Robinson.  The Science of the Placebo , 2008 .

[2]  A. Schatzberg,et al.  Extended treatment with bupropion SR for cigarette smoking cessation. , 2006, Journal of consulting and clinical psychology.

[3]  E. Wouters,et al.  Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.

[4]  Richard A. Brown,et al.  Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[5]  L. Epstein,et al.  Effect of bupropion on depression symptoms in a smoking cessation clinical trial. , 2004, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[6]  E. Hudes,et al.  Bupropion for smoking cessation: a randomized trial. , 2004, Archives of internal medicine.

[7]  T. Robinson,et al.  Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. , 2004, Journal of consulting and clinical psychology.

[8]  Caryn Lerman,et al.  Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. , 2004, The American journal of clinical nutrition.

[9]  D. Hatsukami,et al.  The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. , 2004, Addictive behaviors.

[10]  L. Epstein,et al.  Changes in food reward following smoking cessation: a pharmacogenetic investigation , 2004, Psychopharmacology.

[11]  Richard A. Brown,et al.  Do small lapses predict relapse to smoking behavior under bupropion treatment? , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[12]  Heejung Bang,et al.  Assessment of blinding in clinical trials. , 2004, Controlled clinical trials.

[13]  L. Epstein,et al.  Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  M. Sayette,et al.  Placebo effects of tobacco smoking and other nicotine intake. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[15]  L. Epstein,et al.  Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. , 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[16]  L. Epstein,et al.  Pharmacogenetic investigation of smoking cessation treatment. , 2002, Pharmacogenetics.

[17]  S. Hall,et al.  Psychological intervention and antidepressant treatment in smoking cessation. , 2002, Archives of general psychiatry.

[18]  N. Desbiens.  In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time? , 2002, Medical hypotheses.

[19]  M. Mayo,et al.  Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. , 2002, JAMA.

[20]  L. Epstein,et al.  Mediating mechanisms for the impact of bupropion in smoking cessation treatment. , 2002, Drug and alcohol dependence.

[21]  W. Velicer,et al.  Biochemical verification of tobacco use and cessation. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[22]  M. M. Ward,et al.  Self-reported abstinence effects in the first month after smoking cessation. , 2001, Addictive behaviors.

[23]  K. Haustein.  Pharmacotherapy of nicotine dependence. , 2000, International journal of clinical pharmacology and therapeutics.

[24]  M. Fiore,et al.  Smoking withdrawal dynamics in unaided quitters. , 2000, Journal of abnormal psychology.

[25]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[26]  K. Perkins,et al.  Low-dose nicotine nasal spray use and effects during initial smoking cessation. , 1996 .

[27]  K. Fagerström,et al.  Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. , 1996, Tobacco control.

[28]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[29]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[30]  D. Hatsukami,et al.  Effect of nicotine on the tobacco withdrawal syndrome , 1984, Psychopharmacology.

[31]  J. Carpenter.  Contributions from psychology to the study of drinking and driving. , 1968, Quarterly journal of studies on alcohol.

[32]  L. Epstein,et al.  Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.

[33]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[34]  Mc Fiore,et al.  Treating Tobacco Use and Dependence , 2000 .

[35]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[36]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.